Status:

RECRUITING

DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions

Lead Sponsor:

Adhera Health, Inc.

Collaborating Sponsors:

Hospital Universitario Miguel Servet, Zaragoza

University of Valencia

Conditions:

Obesity, Childhood

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this feasibility study is to explore the needs of families with children with obesity and evaluate the impact of a combined intervention (children with obesity receiving pharmacological th...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Caregivers of children between 13 and 18 years who are diagnosed with obesity and undergoing treatment according to the approved label by AEMPS1 (adolescents with obesity aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex).
  • Families of children with obesity who have been under pharmacological treatment before screening. This includes treatment with any of the following medications orlistat, metformin, liraglutide, semaglutide.
  • Participants who are willing to join ACDP® for 10 months and can interact with a smartphone during that time.
  • The family is willing to complement the pharmacological obesity treatment with a digital intervention.
  • Participants (patients and their caregivers) must be willing to use wearables for the entire length of the study.
  • Parents previously using a wearable will agree not to use it during the length of the study, as their wearable account must be synched to the patient's device. Further, they may need to agree on changing the account data for height, weight, and gender in their Google account.
  • Exclusion criteria:
  • Families not fluent in Spanish.
  • Families of children with obesity and comorbidities.
  • Families of children with secondary causes of obesity (i.e., hypothalamic, genetic or endocrine causes).

Exclusion

    Key Trial Info

    Start Date :

    March 11 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2026

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06520787

    Start Date

    March 11 2025

    End Date

    May 1 2026

    Last Update

    December 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Universitario Miguel Servet

    Zaragoza, Aragon, Spain, 50009